BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
PBX1
,
G-protein-coupled receptor binding
,
Diabetes mellitus
,
Lymphocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
chek1 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast adenocarcinoma MDA-MB-231 cells with knockdown of TRA2a and TRA2b
Explore Curated Studies Results
Literature
Most Relevant Literature
Bioinformatic analysis of CHEK1 as a marker of glomerular epithelial cell injury in diabetic nephrop…
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine …
Maternal heterozygous mutation in CHEK1 leads to mitotic arrest in human zygotes.
CaMKK2 and CHK1 phosphorylate human STN1 in response to replication stress to protect stalled forks …
Determination of CHK1 Cellular Localization by Immunofluorescence Microscopy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes
Nivolumab and Veliparib in Treating Patients With Recurrent or Refractory Stage IV Solid Tumors That…
Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmon…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ